Days with severe symptoms: an additional efficacy endpoint in immunotherapy trials. (2011)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/j.1398-9995.2010.02434.x

PubMed Identifier: 20608918

Publication URI: http://europepmc.org/abstract/MED/20608918

Type: Journal Article/Review

Volume: 66

Parent Publication: Allergy

Issue: 1

ISSN: 0105-4538